Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001415889-24-016518

Chief Executive Officer sold 5,000 shares at an average $17.65 ($88,264)

  • Chief Executive Officer acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Townsend Richard Nolan Chief Executive Officer 2024-06-10 Option exercise 10b5-1 +5,000 $2.33 $11,650 175,695 D
Townsend Richard Nolan Chief Executive Officer 2024-06-10 Sale 10b5-1 −2,962 $17.29 $51,213 172,733 D
Townsend Richard Nolan Chief Executive Officer 2024-06-10 Sale 10b5-1 −2,038 $18.18 $37,051 170,695 D
Derivatives
Townsend Richard Nolan Chief Executive Officer 2024-06-10 Option exercise · Stock Option (right to buy) 10b5-1 −5,000 143,655 D
Open-market sales · 5,000 sh · avg $17.65 · $88,264
Loading xslF345X05/form4-06122024_050602.xml…